Pulse Biosciences, Inc.
PLSE
Rangering i aksjer
#4185
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Aksjekurs
$52.97
Markedsverdi
$3.78B
Endring (1 dag)
3.23%
Endring (1 år)
207.04%
Land
US
Handel Pulse Biosciences, Inc. (PLSE)
Kategori
Healthcare
Aksjeprishistorikk for Pulse Biosciences, Inc. (PLSE)
Høyeste sluttskurs: $49.44 den 2026-10-01
Laveste sluttskurs: $4.20 den 2016-05-01
Laveste sluttskurs: $4.20 den 2016-05-01
Aksjeprishistorikk for Pulse Biosciences, Inc. fra 2016 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | 91.57% |
| 2025 | -23.80% |
| 2024 | 72.60% |
| 2023 | 322.28% |
| 2022 | -84.88% |
| 2021 | -15.48% |
| 2020 | 41.40% |
| 2019 | 19.04% |
| 2018 | -50.17% |
| 2017 | 306.74% |
| 2016 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $442.26 | -16.08% |
US
|
|
| $197.82 | -45.30% |
FR
|
|
| $170.48 | 12.48% |
JP
|
|
| $198.14 | 33.98% |
US
|
|
| $70.09 | -8.42% |
CH
|
